Ferrer CC, Marguet T, Vanwonterghem L, Erbek S, et al. Serum IGF1 is a prognostic marker for resistance to targeted therapies and a predictive marker for anti-IGF1R therapy in melanoma. J Invest Dermatol 2023 Aug 12:S0022-202X(23)02499.
PMID: 37580013